Samsung Biologics Co.,Ltd.
207940
Classifica tra le azioni
#496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Prezzo delle azioni
$1,028.49
Capitalizzazione di mercato
$47.88B
Variazione (1 giorno)
-3.67%
Variazione (1 anno)
-18.37%
Paese
KR
Scambia Samsung Biologics Co.,Ltd. (207940)
Categoria
Healthcare
Utile per Samsung Biologics Co.,Ltd. (207940)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Samsung Biologics Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Samsung Biologics Co.,Ltd. dal 2014 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2025 | $1.47B | 55.69% |
| 2024 | $941.97M | 8.88% |
| 2023 | $865.17M | 8.20% |
| 2022 | $799.60M | 69.37% |
| 2021 | $472.11M | 92.69% |
| 2020 | $245.01M | 82.02% |
| 2019 | $134.61M | -50.53% |
| 2018 | $272.09M | -350.00% |
| 2017 | $-108.84M | -43.17% |
| 2016 | $-191.50M | -109.05% |
| 2015 | $2.12B | -2,423.97% |
| 2014 | $-91.10M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $3.01B | - |
BE
|
|
| $1.95B | - |
NL
|
